ARIAD Pharmaceuticals Inc (NASDAQ:ARIA)

9.07
Delayed Data
As of May 22
 +0.23 / +2.60%
Today’s Change
4.90
Today|||52-Week Range
9.89
+32.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues25.3M558.0K45.6M105.4M
 
 
 
 
 
Cost of Goods Sold----5.5M817.0K
 
 
 
Depreciation And Amortization4.6M3.0M4.1M8.8M
 
 
 
 
 
 
Operating ExpensesGross Income----35.9M95.8M
 
 
 
General Expenses97.5M197.8M304.7M256.0M
 
 
 
 
 
Research And Development77.7M139.9M160.7M120.6M
 
 
 
 
 
Total Operating Expenses102.1M200.8M314.3M265.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-76.8M-200.3M-268.8M-160.2M
 
 
 
 
 
Extraordinary Credit0.00--0.004.8M
 
 
Extraordinary Charge-46.7M-20.7M-4.8M0.00
 
 
 
 
Interest Expense On Debt232.0K199.0K153.0K8.1M
 
 
 
 
 
Other Expenses0.0071.0K-130.0K1.4M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-123.6M-220.9M-273.7M-162.0M
 
 
 
 
 
Income Taxes0.000.00-439.0K-630.0K
 
 
 
Net Income-123.6M-220.9M-274.2M-162.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS132.4M165.0M183.6M186.8M
 
 
 
 
 
Shares To Calculate EPS Diluted132.4M165.0M183.6M186.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.93-$1.34-$1.49-$0.87
 
 
 
 
 
EPS Diluted-$0.93-$1.34-$1.49-$0.87
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account